General program - in its founding year, the institute mapped out the full landscape of stakeholders essential to advancing progress against ewing sarcoma. Leadership met with researchers, clinicians, scientists, industry representatives, and patient advocates, and engaged directly with key ewing sarcoma organizations, partners, and initiatives working in the field. Through these efforts, the insti… Read more
General program - in its founding year, the institute mapped out the full landscape of stakeholders essential to advancing progress against ewing sarcoma. Leadership met with researchers, clinicians, scientists, industry representatives, and patient advocates, and engaged directly with key ewing sarcoma organizations, partners, and initiatives working in the field. Through these efforts, the institute developed a comprehensive understanding of the current state of ewing sarcoma research and care, and identified opportunities to strengthen coordination across traditionally siloed groups. This foundational work established the collaborative architecture upon which the institute's research funding and scientific programming will be built in subsequent years.
$9,816 spent · 46.2% of program spending
Community & parent engagement - in its founding year, the institute launched its community engagement program by uniting the historically fragmented ewing sarcoma advocate and philanthropic communities in shared purpose. The institute met with dozens of foundations focused on ewing sarcoma and pediatric cancer to build philanthropic alignment and identify coordinated funding strategies. It also en… Read more
Community & parent engagement - in its founding year, the institute launched its community engagement program by uniting the historically fragmented ewing sarcoma advocate and philanthropic communities in shared purpose. The institute met with dozens of foundations focused on ewing sarcoma and pediatric cancer to build philanthropic alignment and identify coordinated funding strategies. It also engaged directly with more than twenty ewing sarcoma patients and families to ensure the patient and caregiver voice informs the institute's research priorities and programmatic direction. Through these efforts, the institute transformed a dispersed landscape of advocacy and giving into an organized community positioned to drive collective impact.
$6,544 spent · 30.8% of program spending
Strategic advisory board - a defining accomplishment of the institute's founding year was the identification, recruitment, and formal seating of its strategic advisory board, comprised of twelve of the world's leading experts in ewing sarcoma. Institute leadership mapped the global landscape of scientific and clinical expertise in the disease and engaged top researchers and clinicians across leadi… Read more
Strategic advisory board - a defining accomplishment of the institute's founding year was the identification, recruitment, and formal seating of its strategic advisory board, comprised of twelve of the world's leading experts in ewing sarcoma. Institute leadership mapped the global landscape of scientific and clinical expertise in the disease and engaged top researchers and clinicians across leading institutions. The resulting board represents the foremost authorities on ewing sarcoma biology, translational research, and clinical care, providing the institute with unparalleled scientific guidance on this rare disease. Establishing the strategic advisory board in the first year provided the scientific credibility and expert oversight needed to guide research investments and programmatic priorities from the outset.
$4,908 spent · 23.1% of program spending
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$50,334Fiscal year 2024
Expenses$33,924Fiscal year 2024
Total assets—Fiscal year 2024
Total liabilities—Fiscal year 2024
Fiscal year ending December2024
Revenue$50,334
Expenses$33,924
Net income$16,410
Net assets$16,410
Notable sources of revenue
Percent of total revenue
Contributions
$50,000
99.3%
Program services
$0
0.0%
Investment income
$334
0.7%
Other (net)
$0
0.0%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$16,410
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?